$GH I don't think this stock is hyped at all. It is in the sweet spot of healthcare and specifically healthcare prevention. With an aging population resources will flow into preventative and early screening healthcare issues. Cancer is about as big as it gets...and GH sits at the throne of cutting edge early screening Cancer research. There is always a risk on stocks like these and biotech because there can be bad news from the FDA or test results that are setbacks. However, I do believe the risks for GH are on the low end of almost any other company like this.
  • 2